CA2723130A1 - A system and method for cell characterisation - Google Patents
A system and method for cell characterisation Download PDFInfo
- Publication number
- CA2723130A1 CA2723130A1 CA2723130A CA2723130A CA2723130A1 CA 2723130 A1 CA2723130 A1 CA 2723130A1 CA 2723130 A CA2723130 A CA 2723130A CA 2723130 A CA2723130 A CA 2723130A CA 2723130 A1 CA2723130 A1 CA 2723130A1
- Authority
- CA
- Canada
- Prior art keywords
- impedance
- cell
- frequency range
- impedance response
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48735—Investigating suspensions of cells, e.g. measuring microbe concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0531—Measuring skin impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0538—Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6862—Stents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/36—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of biomass, e.g. colony counters or by turbidity measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
- G01N27/026—Dielectric impedance spectroscopy
Abstract
A method for characterising cells or cell structures in a sample comprising:
obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.
obtaining at least one normalized impedance response of the sample over at least one frequency range; and characterising at least one cell using at least one characteristic of the normalized impedance response.
Description
A System and Method for Cell Characterisation The present invention relates to a system and method for characterising cells and structures formed from cells.
Background of the Invention Various techniques have been reported for monitoring growth or other characteristics of biological cells. One such technique involves the use of impedance methods, as reported by Lind R et. al. in "Single Cell Mobility and Adhesion Monitoring Using Extracellular Electrodes", Biosensors and Bioelectronics, 6 (4), pp 359-367, 1991.
Other reported techniques involve determining changes in impedance and linking these to cell or bacterial growth or movement.
Most of these techniques involve measuring ac impedance of cells or bacteria in their appropriate growth media. A good degree of success has been achieved in using these methods to link overall changes in impedance, Z, at some fixed electrical stimulating frequency, typically in the kilohertz range, to the growth of cells and bacteria. However, the use of impedance techniques for monitoring growth or other characteristics of biological cells is complicated by the fact that each measuring system has its own characteristic impedance, which must be separated from the impedance response of the cells.
Summary of Invention According to a first aspect of the present invention, there is provided a method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range;
and characterising at least one cell using at least one characteristic of the normalized impedance response.
By monitoring the frequency response of normalised impedance over a spectrum of frequencies, it has been found that characteristic features in the frequency response of normalised impedance may be identified and used to classify cells in a consistent and repeatable manner. The use of normalised impedance has the further advantage that there is no need to continuously separately characterise the electrodes. Furthermore, the AC impedance technique is quick, simple and removing the need for constant recalibration allows continual monitoring of cell cultures.
CONFIRMATION COPY
The frequency range may be a continuous or quasi-continuous frequency range or spectrum. The frequency range may comprise a series of discrete frequency measurements. The frequency range may be any frequency range lying between 0.1 Hz and 33 MHz.
The method may include providing a system having at least two electrodes. The sample may be provided in an electrical path between the electrodes.
The at least one cell may be a bacteria or other single cell organism. The at least one cell may be a plant or animal cell such as a plant or animal tissue cell.
At least one cell may be arranged in a structure, which may be plant or animal tissue or a multi-cell organism.
The method may comprise obtaining a baseline impedance response of the system over the at least one frequency range.
The baseline impedance response may be obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between the electrodes.
The baseline impedance response may be an initial or a calculated or estimated or standard impedance response of the system. The baseline impedance response may be obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between the electrodes.
The method may comprise obtaining at least one measured impedance response of the system over the at least one frequency range.
The at least one measured impedance response of the system over the at least one frequency range may be obtained after introduction and/or growth of at least one cell in the electrical path between the electrodes.
Obtaining the at least one normalized impedance response may comprise dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
Background of the Invention Various techniques have been reported for monitoring growth or other characteristics of biological cells. One such technique involves the use of impedance methods, as reported by Lind R et. al. in "Single Cell Mobility and Adhesion Monitoring Using Extracellular Electrodes", Biosensors and Bioelectronics, 6 (4), pp 359-367, 1991.
Other reported techniques involve determining changes in impedance and linking these to cell or bacterial growth or movement.
Most of these techniques involve measuring ac impedance of cells or bacteria in their appropriate growth media. A good degree of success has been achieved in using these methods to link overall changes in impedance, Z, at some fixed electrical stimulating frequency, typically in the kilohertz range, to the growth of cells and bacteria. However, the use of impedance techniques for monitoring growth or other characteristics of biological cells is complicated by the fact that each measuring system has its own characteristic impedance, which must be separated from the impedance response of the cells.
Summary of Invention According to a first aspect of the present invention, there is provided a method for characterising cells or cell structures in a sample comprising: obtaining at least one normalized impedance response of the sample over at least one frequency range;
and characterising at least one cell using at least one characteristic of the normalized impedance response.
By monitoring the frequency response of normalised impedance over a spectrum of frequencies, it has been found that characteristic features in the frequency response of normalised impedance may be identified and used to classify cells in a consistent and repeatable manner. The use of normalised impedance has the further advantage that there is no need to continuously separately characterise the electrodes. Furthermore, the AC impedance technique is quick, simple and removing the need for constant recalibration allows continual monitoring of cell cultures.
CONFIRMATION COPY
The frequency range may be a continuous or quasi-continuous frequency range or spectrum. The frequency range may comprise a series of discrete frequency measurements. The frequency range may be any frequency range lying between 0.1 Hz and 33 MHz.
The method may include providing a system having at least two electrodes. The sample may be provided in an electrical path between the electrodes.
The at least one cell may be a bacteria or other single cell organism. The at least one cell may be a plant or animal cell such as a plant or animal tissue cell.
At least one cell may be arranged in a structure, which may be plant or animal tissue or a multi-cell organism.
The method may comprise obtaining a baseline impedance response of the system over the at least one frequency range.
The baseline impedance response may be obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between the electrodes.
The baseline impedance response may be an initial or a calculated or estimated or standard impedance response of the system. The baseline impedance response may be obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between the electrodes.
The method may comprise obtaining at least one measured impedance response of the system over the at least one frequency range.
The at least one measured impedance response of the system over the at least one frequency range may be obtained after introduction and/or growth of at least one cell in the electrical path between the electrodes.
Obtaining the at least one normalized impedance response may comprise dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
The at least one characteristic of the normalized impedance response may be frequency dependent. The at least one characteristic of the normalized impedance response may be the frequency and/or the peak size and/or peak shape of at least one peak in the normalized impedance response over the frequency range.
Multiple peaks may be observed in the normalised impedance. The peak or peaks may be dependent upon cell or bacterial activity. Such single or multiple peaks may be used to determine the stage of growth of a cell or bacterial system. Changes in at least one peak obtained in the normalised system may be tracked over time to allow the distinction of changes in cell or bacterial growth.
The at least one peak in normalised impedance with frequency may be characteristic of cell or bacterial type and/or growth stage. Thus the normalised impedance may be used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
The electrodes may be immersed in a culture medium. The culture medium may be arranged to promote the growth of at least one type of cells. The at least one cell may be contained within the medium. The at least one cell may be in contact with one or more of the electrodes.
The measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system may be made using AC impedance techniques.
According to a second aspect of the present invention, there is provided a system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
The controller may be arranged to determine impedance via AC impedance techniques.
Multiple peaks may be observed in the normalised impedance. The peak or peaks may be dependent upon cell or bacterial activity. Such single or multiple peaks may be used to determine the stage of growth of a cell or bacterial system. Changes in at least one peak obtained in the normalised system may be tracked over time to allow the distinction of changes in cell or bacterial growth.
The at least one peak in normalised impedance with frequency may be characteristic of cell or bacterial type and/or growth stage. Thus the normalised impedance may be used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
The electrodes may be immersed in a culture medium. The culture medium may be arranged to promote the growth of at least one type of cells. The at least one cell may be contained within the medium. The at least one cell may be in contact with one or more of the electrodes.
The measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system may be made using AC impedance techniques.
According to a second aspect of the present invention, there is provided a system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
The controller may be arranged to determine impedance via AC impedance techniques.
The electrodes may be adapted to be immersed in a growth medium. The electrodes may be gold, silver chloride or carbon electrodes. The electrodes may be planar electrodes. The electrodes may be arranged for in vitro or in-vivo measurement.
The electrodes may be affixed to and/or at least part of an implantable device. The implantable device may be a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
The frequency range may preferably be any frequency range lying between 0.001 Hz and 33 MHz. Optionally the frequency range may be any frequency range above 0.001 Hz. In some applications, dc voltage or current for baseline and normalisation calculations may be used.
The system may be arranged to obtain a baseline impedance response over a frequency range.
The system may be arranged to obtain at least one measured impedance response over the frequency range. The at least one measured impedance response may include both real and imaginary parts of the impedance or may comprise only real or only imaginary parts of the impedance.
The system may be adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
According to a third aspect of the present invention is an implantable device comprising at least one electrode, the implantable device being adapted for use with the method of the first aspect and/or the system of the second aspect.
The implantable device may preferably be a stent, a prosthesis or a replacement organ and/or may optionally be any implantable medical device having a bare metal surface or that has had a metal surface introduced.
The electrodes may be affixed to and/or at least part of an implantable device. The implantable device may be a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
The frequency range may preferably be any frequency range lying between 0.001 Hz and 33 MHz. Optionally the frequency range may be any frequency range above 0.001 Hz. In some applications, dc voltage or current for baseline and normalisation calculations may be used.
The system may be arranged to obtain a baseline impedance response over a frequency range.
The system may be arranged to obtain at least one measured impedance response over the frequency range. The at least one measured impedance response may include both real and imaginary parts of the impedance or may comprise only real or only imaginary parts of the impedance.
The system may be adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
According to a third aspect of the present invention is an implantable device comprising at least one electrode, the implantable device being adapted for use with the method of the first aspect and/or the system of the second aspect.
The implantable device may preferably be a stent, a prosthesis or a replacement organ and/or may optionally be any implantable medical device having a bare metal surface or that has had a metal surface introduced.
Brief Description of the Drawings Various aspects of the invention will now be described by way of example only with reference to the accompanying drawings, of which:
Figure 1 is a system for characterising cells;
Figure 2 is a flow diagram of a method for characterising cells;
Figure 3 shows the frequency response of the normalised impedance of smooth muscle cells obtained using the system of Figure 1 and the method of Figure 2;
Figure 4 shows the frequency response of the normalised impedance of smooth muscle cells, epithelial cells and endothelial cells obtained using the system of Figure 1 and the method of Figure 2; and Figure 5 shows the frequency response of the normalised impedance of staphylococcus aureus bacteria obtained using the system of Figure 1 and the method of Figure 2.
Detailed Description of the Drawings Figure 1 shows an apparatus 5 for characterising biological cells 10, such as plant or animal cells, bacteria, plant or animal tissue, multicellular organisms, archaea and the like. The apparatus 5 comprises a controller 15 for providing an electrical signal to, and obtaining an electrical response from a measurement system 20 comprising two planar gold electrodes 25 located within a container 30 for holding growth medium 35. The growth medium 35 is conductive such that when the container 30 is filled, an electrical circuit is completed including the electrodes 25, the controller 15 and the growth medium 35.
The controller 15 is arranged to perform AC impedance spectroscopy by monitoring the impedance response of the system 20 to a small AC perturbation current over a range of frequencies. This involves applying an electrical stimulus between the electrodes 25 and measuring the magnitude and phase of the current and voltage between at least two points in the electrical path between them. In this case, the measurement points are at the electrodes 25 themselves. However, a skilled person would appreciate that alternate embodiments are possible wherein one or more additional measurement electrodes are used. The measured voltages and currents can be used to determine the impedance of the system and the magnitude and/or phase and/or phase difference of the impedance, voltage and/or current can be analysed to determine properties of the electrical circuit.
A method of characterising cells located in the electrical path between the electrodes 25 is outlined in Figure 2. Preparation for the characterisation, indicated at step 40, involves cleaning the electrodes 25 or providing fresh electrodes 25 in order to remove any contamination or oxidation from surfaces of the electrodes 25, which may otherwise lead to spurious results. The container 30 is then filled with a growth medium 35 suitable for growing the desired cells, such that the electrodes 25 are immersed in the growth medium 35. The growth medium 35 may be any suitable conductive and electrochemically stable growth medium known in the art.
The controller 15 is operable to carry out an AC impedance sweep of the system 20, measuring the impedance of the system 20 over a selected frequency range, f, in order to collect a baseline impedance response, Zmeasured(f,t=0), for that system 20 and frequency range, as indicated in step 45. The frequency sweep range, f, can be set to a range indicative of a cell or cells to be investigated or a broad sweep can be performed, for example, if the cell type or types are unknown or a wide range of cell types are being characterised. Typically, frequencies between 0.1 Hz and 32MHz are suitable for characterising most cell types.
The swept frequency range can include one or more frequency sub-ranges, wherein each sub-range may be selected to investigate an expected impedance response.
Further, although the measurement is carried out by collecting data for frequency spectra rather than an individual frequency, it will be appreciated that some apparatus, particularly digital apparatus, may collect a quasi-continuous frequency range by collecting a series of measurements at discrete frequencies, each frequency being separated by a frequency step. The frequency step is selected to be sufficiently small such that the series of discrete frequencies appears to be continuous. Alternatively, a continuous range can be obtained by interpolating the discrete points.
In some circumstances, the baseline impedance response may not be known, or collection of such data may be inconvenient. In these cases, it is possible to construct a similar or standard electrode system and obtain an approximation of the baseline impedance response Zmeasured(f,t=0). However, if the electrodes 25 are implanted or part of an implanted / in-vivo system, then it is preferable to collect a baseline impedance response in situ, due to the complexity of the growth medium and electrode arrangement, which may be difficult to approximate.
Once collected or approximated baseline data has been obtained, then the cells to be analysed are introduced and/or grown in the growth medium in step 50. In step 55, the controller 15 is then operable to carry out at least one further AC
impedance sweep of the system 20, measuring the impedance of the system 20 over the selected frequency range, f, in order to collect at least one measured impedance response, Zmeasured(f,t).
The measured impedance response Zmeasured(f,t) for the frequency range is then divided by the corresponding baseline impedance response Zmeasured(f,t=0) for the frequency range to obtain the normalized frequency, Zn(f,t), in step 60. For embodiments where the impedance response is measured as a quasi-continuous series of impedance values at discrete frequencies, the measured impedance response for each discrete frequency in the frequency range is divided by the baseline impedance response for that frequency.
For dynamic systems, where the cell composition or type is changing or where cells are growing and/or multiplying in the growth medium 35, the measured impedance response Zmeasured(f,t) can be redetermined and the cells 10 recharacterised at regular time intervals. In this way, the evolution of the cells within the system over time can be monitored.
The change of the frequency dependence of normalised impedance over time with growth of smooth cardiac muscle cells is shown in Figure 3. It can be seen from this that a peak 65 in the normalised impedance appears as the cardiac cell culture grows. At confluence, i.e. when the electrodes are covered by cells, the peak characteristic of this type of cell can be seen to occur at just under 3000Hz.
Without wishing to be bound by any particular theory, it is likely that the peak 65 is due to individual cell 10 components contributing to the resistance and capacitance of the system 20 and to interactions between the cell culture and the electrodes 25.
Some small amounts of inductance may also contribute to the response.
By determining the frequency at which the peaks 65 occur the cells 10 in step 70 can be characterised. Alternatively, more advanced techniques such as model fitting, magnitude of the normalised impedance and peak fitting may be used. The peak positions can be compared with characteristic peak positions stored in a look up table in order to identify cell type. Optionally, equivalent circuit analysis can be used instead of peak fitting. Equivalent circuit analysis can yield values for cell or bacteria resistance and capacitance that are characteristic of the organism and/or its stage of growth.
To demonstrate the ability of this technique to differentiate between cell types, the above method was repeated separately for epithelial cells and endothelial cells. As can be seen from the results, as shown in Figure 4, at confluence, the frequency response of normalised impedance for epithelial cells peaks at approximately 1000Hz, the peak for smooth muscle cells is closer to 2000Hz whilst the peak for endothelial cells is closer to 20000Hz. In this way, when faced with three unknown cell types, the apparatus and method as described above are able to characterise the cell type based on the position of characteristic peaks in the frequency response of the normalised impedance at confluence.
The utility of this technique lies not only in characterisation of tissue cells, but surprisingly it can also be used to characterise other cell types and cellular organisms. As an example, the above cell characterisation method was applied to a staphylococcus aureus bacteria culture in a bacterial broth growth medium. As can be seen from the resulting normalised impedance spectrum, as shown in Figure 5, a number of peaks in normalised impedance are obtained at certain characteristic frequencies. These peaks are useable to characterise the bacteria in question.
Each curve is characteristic of the type of bacteria and stage of growth.
In an embodiment of the present invention, at least the electrodes 25 can be incorporated on or in, or form at least part of, an implantable device. The implantable device may be a dedicated sensor, or alternatively, the implantable device can be a medical implant or prosthesis, such as a stent, or a replacement organ or part of an organ such as a heart valve. In this way, the environment and condition of the implantable device can be monitored. For example, the degree of restinosis forming around a stent can be detected and quantified or the formation of scar tissue around an implant can be determined or bacterial infection within the body may be identified.
In another example, if the electrode system is placed within a wound dressing close to the surface of a wound, it can be used to signal both the presence of a bacterial infection and the type of bacteria. It can also be seen that such a system could be employed in a small instrument for use in characterising cell cultures, or used as an instrument for characterising wound swabs or surface swabs in the laboratory.
A skilled person will appreciate that variations of the disclosed arrangements are possible without departing from the scope of the invention. For example, although the apparatus 5 described above uses gold electrodes 25, it will be appreciated that other materials, such as platinum, may be used. The above method and apparatus may be applied to a range of applications such as determining the degree of restenosis, in body scientific investigations, detection of chemical materials, calcification, etc. Although a two electrode 25 system. having a working electrode and a counter electrode is described, it will be appreciated that other electrode arrangements, such as at least one additional measurement electrode, may be used.
Although the electrodes 35 described above are planar, it will be appreciated that other conformations of electrode may be used, particularly if an electrode 25 is incorporated into an implantable device, wherein the electrodes 25 may be conformed to the shape of the device. Although the control unit 15 and the electrodes 25 are described as being directly coupled through wires, it will be appreciated that other coupling means may be provided, such as inductive coupling or wireless coupling, particularly for implantable in-vivo devices.
Figure 1 is a system for characterising cells;
Figure 2 is a flow diagram of a method for characterising cells;
Figure 3 shows the frequency response of the normalised impedance of smooth muscle cells obtained using the system of Figure 1 and the method of Figure 2;
Figure 4 shows the frequency response of the normalised impedance of smooth muscle cells, epithelial cells and endothelial cells obtained using the system of Figure 1 and the method of Figure 2; and Figure 5 shows the frequency response of the normalised impedance of staphylococcus aureus bacteria obtained using the system of Figure 1 and the method of Figure 2.
Detailed Description of the Drawings Figure 1 shows an apparatus 5 for characterising biological cells 10, such as plant or animal cells, bacteria, plant or animal tissue, multicellular organisms, archaea and the like. The apparatus 5 comprises a controller 15 for providing an electrical signal to, and obtaining an electrical response from a measurement system 20 comprising two planar gold electrodes 25 located within a container 30 for holding growth medium 35. The growth medium 35 is conductive such that when the container 30 is filled, an electrical circuit is completed including the electrodes 25, the controller 15 and the growth medium 35.
The controller 15 is arranged to perform AC impedance spectroscopy by monitoring the impedance response of the system 20 to a small AC perturbation current over a range of frequencies. This involves applying an electrical stimulus between the electrodes 25 and measuring the magnitude and phase of the current and voltage between at least two points in the electrical path between them. In this case, the measurement points are at the electrodes 25 themselves. However, a skilled person would appreciate that alternate embodiments are possible wherein one or more additional measurement electrodes are used. The measured voltages and currents can be used to determine the impedance of the system and the magnitude and/or phase and/or phase difference of the impedance, voltage and/or current can be analysed to determine properties of the electrical circuit.
A method of characterising cells located in the electrical path between the electrodes 25 is outlined in Figure 2. Preparation for the characterisation, indicated at step 40, involves cleaning the electrodes 25 or providing fresh electrodes 25 in order to remove any contamination or oxidation from surfaces of the electrodes 25, which may otherwise lead to spurious results. The container 30 is then filled with a growth medium 35 suitable for growing the desired cells, such that the electrodes 25 are immersed in the growth medium 35. The growth medium 35 may be any suitable conductive and electrochemically stable growth medium known in the art.
The controller 15 is operable to carry out an AC impedance sweep of the system 20, measuring the impedance of the system 20 over a selected frequency range, f, in order to collect a baseline impedance response, Zmeasured(f,t=0), for that system 20 and frequency range, as indicated in step 45. The frequency sweep range, f, can be set to a range indicative of a cell or cells to be investigated or a broad sweep can be performed, for example, if the cell type or types are unknown or a wide range of cell types are being characterised. Typically, frequencies between 0.1 Hz and 32MHz are suitable for characterising most cell types.
The swept frequency range can include one or more frequency sub-ranges, wherein each sub-range may be selected to investigate an expected impedance response.
Further, although the measurement is carried out by collecting data for frequency spectra rather than an individual frequency, it will be appreciated that some apparatus, particularly digital apparatus, may collect a quasi-continuous frequency range by collecting a series of measurements at discrete frequencies, each frequency being separated by a frequency step. The frequency step is selected to be sufficiently small such that the series of discrete frequencies appears to be continuous. Alternatively, a continuous range can be obtained by interpolating the discrete points.
In some circumstances, the baseline impedance response may not be known, or collection of such data may be inconvenient. In these cases, it is possible to construct a similar or standard electrode system and obtain an approximation of the baseline impedance response Zmeasured(f,t=0). However, if the electrodes 25 are implanted or part of an implanted / in-vivo system, then it is preferable to collect a baseline impedance response in situ, due to the complexity of the growth medium and electrode arrangement, which may be difficult to approximate.
Once collected or approximated baseline data has been obtained, then the cells to be analysed are introduced and/or grown in the growth medium in step 50. In step 55, the controller 15 is then operable to carry out at least one further AC
impedance sweep of the system 20, measuring the impedance of the system 20 over the selected frequency range, f, in order to collect at least one measured impedance response, Zmeasured(f,t).
The measured impedance response Zmeasured(f,t) for the frequency range is then divided by the corresponding baseline impedance response Zmeasured(f,t=0) for the frequency range to obtain the normalized frequency, Zn(f,t), in step 60. For embodiments where the impedance response is measured as a quasi-continuous series of impedance values at discrete frequencies, the measured impedance response for each discrete frequency in the frequency range is divided by the baseline impedance response for that frequency.
For dynamic systems, where the cell composition or type is changing or where cells are growing and/or multiplying in the growth medium 35, the measured impedance response Zmeasured(f,t) can be redetermined and the cells 10 recharacterised at regular time intervals. In this way, the evolution of the cells within the system over time can be monitored.
The change of the frequency dependence of normalised impedance over time with growth of smooth cardiac muscle cells is shown in Figure 3. It can be seen from this that a peak 65 in the normalised impedance appears as the cardiac cell culture grows. At confluence, i.e. when the electrodes are covered by cells, the peak characteristic of this type of cell can be seen to occur at just under 3000Hz.
Without wishing to be bound by any particular theory, it is likely that the peak 65 is due to individual cell 10 components contributing to the resistance and capacitance of the system 20 and to interactions between the cell culture and the electrodes 25.
Some small amounts of inductance may also contribute to the response.
By determining the frequency at which the peaks 65 occur the cells 10 in step 70 can be characterised. Alternatively, more advanced techniques such as model fitting, magnitude of the normalised impedance and peak fitting may be used. The peak positions can be compared with characteristic peak positions stored in a look up table in order to identify cell type. Optionally, equivalent circuit analysis can be used instead of peak fitting. Equivalent circuit analysis can yield values for cell or bacteria resistance and capacitance that are characteristic of the organism and/or its stage of growth.
To demonstrate the ability of this technique to differentiate between cell types, the above method was repeated separately for epithelial cells and endothelial cells. As can be seen from the results, as shown in Figure 4, at confluence, the frequency response of normalised impedance for epithelial cells peaks at approximately 1000Hz, the peak for smooth muscle cells is closer to 2000Hz whilst the peak for endothelial cells is closer to 20000Hz. In this way, when faced with three unknown cell types, the apparatus and method as described above are able to characterise the cell type based on the position of characteristic peaks in the frequency response of the normalised impedance at confluence.
The utility of this technique lies not only in characterisation of tissue cells, but surprisingly it can also be used to characterise other cell types and cellular organisms. As an example, the above cell characterisation method was applied to a staphylococcus aureus bacteria culture in a bacterial broth growth medium. As can be seen from the resulting normalised impedance spectrum, as shown in Figure 5, a number of peaks in normalised impedance are obtained at certain characteristic frequencies. These peaks are useable to characterise the bacteria in question.
Each curve is characteristic of the type of bacteria and stage of growth.
In an embodiment of the present invention, at least the electrodes 25 can be incorporated on or in, or form at least part of, an implantable device. The implantable device may be a dedicated sensor, or alternatively, the implantable device can be a medical implant or prosthesis, such as a stent, or a replacement organ or part of an organ such as a heart valve. In this way, the environment and condition of the implantable device can be monitored. For example, the degree of restinosis forming around a stent can be detected and quantified or the formation of scar tissue around an implant can be determined or bacterial infection within the body may be identified.
In another example, if the electrode system is placed within a wound dressing close to the surface of a wound, it can be used to signal both the presence of a bacterial infection and the type of bacteria. It can also be seen that such a system could be employed in a small instrument for use in characterising cell cultures, or used as an instrument for characterising wound swabs or surface swabs in the laboratory.
A skilled person will appreciate that variations of the disclosed arrangements are possible without departing from the scope of the invention. For example, although the apparatus 5 described above uses gold electrodes 25, it will be appreciated that other materials, such as platinum, may be used. The above method and apparatus may be applied to a range of applications such as determining the degree of restenosis, in body scientific investigations, detection of chemical materials, calcification, etc. Although a two electrode 25 system. having a working electrode and a counter electrode is described, it will be appreciated that other electrode arrangements, such as at least one additional measurement electrode, may be used.
Although the electrodes 35 described above are planar, it will be appreciated that other conformations of electrode may be used, particularly if an electrode 25 is incorporated into an implantable device, wherein the electrodes 25 may be conformed to the shape of the device. Although the control unit 15 and the electrodes 25 are described as being directly coupled through wires, it will be appreciated that other coupling means may be provided, such as inductive coupling or wireless coupling, particularly for implantable in-vivo devices.
Claims (29)
1 1. A method for characterising cells or cell structures in a sample comprising:
obtaining at least one normalized impedance response of the sample over at least one frequency range, wherein the normalised impedance is a measured impedance divided by a baseline impedance; and characterising at least one cell using at least one characteristic of the normalized impedance response.
obtaining at least one normalized impedance response of the sample over at least one frequency range, wherein the normalised impedance is a measured impedance divided by a baseline impedance; and characterising at least one cell using at least one characteristic of the normalized impedance response.
2. A method according to claim 1, wherein the frequency range is a continuous or quasi-continuous frequency range or spectrum.
3. A method according to claim 1 or claim 2, wherein the frequency range comprises a series of discrete frequency measurements.
4. A method according to any of the preceding claims, wherein the frequency range is any frequency range lying between 0.1 Hz and 33 MHz.
5. A method according to any of the preceding claims, wherein the at least one cell is a bacteria or other single cell organism and/or the at least one call is a plant or animal cell such as a plant or animal tissue cell and/or at least one cell is arranged in a structure, such as plant or animal tissue or a multi-cell organism.
6. A method according to any of the preceding claims, wherein the baseline impedance response is obtained by measuring the impedance response of the system over the frequency range with substantially no cells in an electrical path between at least two electrodes.
7. A method according to any of claims 1 to 5, wherein the baseline impedance response is an initial or a calculated or estimated or standard impedance response of the system.
8. A method according to claim 7, wherein the baseline impedance response is obtained by measuring the impedance response of a similar and/or standardised system over the at least one frequency range with substantially no cells in an electrical path between at least two electrodes.
9. A method according to any of the preceding claims, wherein the at least one measured impedance response of the system over the at least one frequency range is obtained after introduction and/or growth of at least one cell in the electrical path between at least two electrodes.
10. A method according to any of the preceding claims, wherein the at least one characteristic of the normalized impedance response is the frequency and/or the peak size and/or peak shape of at least one peak in the normalized impedance response over the frequency range.
11. A method according to claim 10, wherein the at least one peak is used to determine the stage of growth of at least one cell or bacterial system.
12. A method according to claim 11, wherein changes in at least one peak in the normalised system is tracked over time to allow the distinction of changes in cell or bacterial growth.
13. A method according to any of claims 10 to 12, wherein at least one peak in normalised impedance with frequency is characteristic of cell or bacterial type and/or growth stage and the normalised impedance is used to determine the presence of a particular cell, bacteria, tissue type or molecular by product in the system.
14. A method according to any of the preceding claims, wherein at least two electrodes used to obtain the normalised impedance response are immersed in a culture medium.
15. A method according to claim 14, wherein the culture medium is arranged to promote the growth of at least one type of cells.
16. A method according to any of the preceding claims, wherein the measurement of the impedance response of the system and/or the baseline impedance response of the system and/or the normalized impedance response of the system is made using AC impedance techniques.
17. A system for characterising cells or cell structures in a sample comprising: at least two electrodes coupled with a controller, the controller being adapted to obtain at least one normalized impedance response from the sample over a frequency range via the electrodes by dividing a measured impedance by a baseline impedance; and characterise at least one cell or cell structure using at least one characteristic of the normalized impedance response.
18. A system according to claim 17, wherein the controller is arranged to determine impedance via AC impedance techniques.
19. A system according to claim 17 or claim 18, wherein the electrodes are adapted to be immersed in a growth medium.
20. A system according to any of claims 17 to 19, wherein the electrodes are gold, silver chloride or carbon electrodes.
21. A system according to any of claims 17 to 20, wherein the electrodes are affixed to and/or at least part of an implantable device.
22. A system according to claim 21, wherein the implantable device is a cardiac stent, a metal heart valve or tissue valve attached to a metal affixing ting or stent, a vascular stent or a metallic surface of an implantable joint such as a hip joint.
23. A system according to any of claims 17 to 22, wherein the frequency range is be any frequency range lying between 0.001Hz and 33 MHz.
24. A system according to any of claim 17 or claims 2 to 23, wherein dc voltage or current is used to determine the normalized impedance.
25. A system according to any of claims 17 to 24, wherein the system is arranged to obtain a baseline impedance response over a frequency range.
26. A system according to any of claims 17 to 23 or claim 25, wherein the at least one measured impedance response includes both real and imaginary parts of the impedance or comprises only real or comprises only imaginary parts of the impedance.
27. A system according to claim 24 or claim 25, wherein the system is adapted to obtain the at least one normalized impedance response by dividing the at least one measured impedance response of the system at each frequency in the frequency range by the baseline impedance response of the system for the corresponding frequency.
28. An implantable device comprising at least one electrode, the implantable device being adapted for use with the method of any of claims 1 to 16 and/or the system of any of claims 17 to 27.
29. The implantable device of claim 28, wherein the implantable device is a stent, a prosthesis or a replacement organ and/or is any implantable medical device having a bare metal surface or that has had a metal surface introduced.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0808266.1 | 2008-05-07 | ||
| GB0808266A GB0808266D0 (en) | 2008-05-07 | 2008-05-07 | System for characterising or monitoring implanted devices |
| GB0906653A GB0906653D0 (en) | 2009-04-17 | 2009-04-17 | A system and method for cell characterisation |
| GB0906653.1 | 2009-04-17 | ||
| PCT/GB2009/001132 WO2009136157A2 (en) | 2008-05-07 | 2009-05-07 | A system and method for cell characterisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2723130A1 true CA2723130A1 (en) | 2009-11-12 |
Family
ID=41114101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2723130A Abandoned CA2723130A1 (en) | 2008-05-07 | 2009-05-07 | A system and method for cell characterisation |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10094818B2 (en) |
| EP (1) | EP2271933B1 (en) |
| JP (1) | JP2011520118A (en) |
| CN (1) | CN102016575B (en) |
| CA (1) | CA2723130A1 (en) |
| DK (1) | DK2271933T3 (en) |
| ES (1) | ES2401235T3 (en) |
| PL (1) | PL2271933T3 (en) |
| WO (1) | WO2009136157A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8635028B2 (en) * | 2009-10-02 | 2014-01-21 | The Curators Of The University Of Missouri | Rapid detection of viable bacteria system and method |
| EP2510342A2 (en) * | 2009-12-09 | 2012-10-17 | ITI Scotland Limited | Detecting analytes |
| DE102010052196B4 (en) | 2010-11-24 | 2015-07-23 | Tutech Innovation Gmbh | Miniaturized device for characterizing biological material |
| US11083391B2 (en) | 2011-06-10 | 2021-08-10 | Cochlear Limited | Electrode impedance spectroscopy |
| US9709516B2 (en) | 2012-02-15 | 2017-07-18 | Becton, Dickinson And Company | Impedance-based bacterial detection system |
| ES2687979T3 (en) * | 2012-06-05 | 2018-10-30 | Nestec S.A. | Diagnostic methods of chronic valvular disease |
| FR3026631B1 (en) | 2014-10-03 | 2016-12-09 | Ecole Polytech | IMPLANTABLE MEDICAL DEVICE WITH SENSORS |
| CN115963149A (en) * | 2014-10-14 | 2023-04-14 | 贝克顿·迪金森公司 | Reactance and capacitance type sensing platform for detecting microorganisms |
| US10234376B2 (en) | 2015-05-12 | 2019-03-19 | Savannah River Nuclear Solutions, Llc | Non-contact monitoring of biofilms and corrosion on submerged surfaces with electrochemical impedance spectroscopy |
| FR3042873A1 (en) * | 2015-10-23 | 2017-04-28 | Ecole Polytech | METHOD AND SYSTEM FOR DISCRIMINATING CELLS |
| FR3049843A1 (en) | 2016-04-06 | 2017-10-13 | Instent | MEDICAL DEVICE PROVIDED WITH SENSORS |
| CN110199358B (en) | 2016-11-21 | 2023-10-24 | 森索姆公司 | Characterization and identification of biological structures |
| US20180266973A1 (en) * | 2017-02-28 | 2018-09-20 | Covidien Lp | Pathogen detection |
| JP7198518B2 (en) * | 2017-04-07 | 2023-01-04 | インペディクス ダイアグノスティクス インコーポレイテッド | Systems and methods for rapid detection of viable microorganisms in liquid media |
| CN107219261B (en) * | 2017-05-12 | 2020-08-04 | 中国科学院电工研究所 | High-density culture cell impedance measuring device |
| CN107890577B (en) * | 2017-10-23 | 2021-04-06 | 南方科技大学 | Sterilization robot system |
| CN108037159B (en) * | 2017-11-02 | 2019-12-03 | 江苏大学 | A kind of cytoactive detection method and device based on impedance spectrum integral feature |
| CN113740423B (en) * | 2021-09-03 | 2022-11-22 | 电子科技大学 | EQCM method for detecting cell morphology change and cell adhesion characteristic change in real time |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545374A (en) * | 1982-09-03 | 1985-10-08 | Jacobson Robert E | Method and instruments for performing a percutaneous lumbar diskectomy |
| US5772661A (en) * | 1988-06-13 | 1998-06-30 | Michelson; Gary Karlin | Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine |
| DE8912648U1 (en) * | 1989-10-23 | 1990-11-22 | Mecron Medizinische Produkte Gmbh, 1000 Berlin, De | |
| US5534028A (en) * | 1993-04-20 | 1996-07-09 | Howmedica, Inc. | Hydrogel intervertebral disc nucleus with diminished lateral bulging |
| BE1007549A3 (en) * | 1993-09-21 | 1995-08-01 | Beckers Louis Francois Charles | Implant. |
| US6309421B1 (en) * | 1994-03-18 | 2001-10-30 | Madhavan Pisharodi | Rotating, locking intervertebral disk stabilizer and applicator |
| US7879095B2 (en) * | 1994-03-18 | 2011-02-01 | Madhavan Pisharodi | Method of inserting, rotating and releasing a spring-loaded artificial disk |
| US5860973A (en) * | 1995-02-27 | 1999-01-19 | Michelson; Gary Karlin | Translateral spinal implant |
| WO1996027348A1 (en) * | 1995-03-08 | 1996-09-12 | Synthes Ag, Chur | Intervertebral implant |
| US6206922B1 (en) * | 1995-03-27 | 2001-03-27 | Sdgi Holdings, Inc. | Methods and instruments for interbody fusion |
| US5792044A (en) * | 1996-03-22 | 1998-08-11 | Danek Medical, Inc. | Devices and methods for percutaneous surgery |
| US6430125B1 (en) * | 1996-07-03 | 2002-08-06 | Zen Research (Ireland), Ltd. | Methods and apparatus for detecting and correcting magnification error in a multi-beam optical disk drive |
| DE19631370A1 (en) * | 1996-08-02 | 1998-02-05 | Hoechst Ag | Hardening agent for epoxy resin systems |
| US6712819B2 (en) * | 1998-10-20 | 2004-03-30 | St. Francis Medical Technologies, Inc. | Mating insertion instruments for spinal implants and methods of use |
| DE59710823D1 (en) * | 1997-08-06 | 2003-11-06 | Synthes Ag | SPREADABLE INTERMEDIATE SPIRAL IMPLANT |
| FR2767675B1 (en) * | 1997-08-26 | 1999-12-03 | Materiel Orthopedique En Abreg | INTERSOMATIC IMPLANT AND ANCILLARY OF PREPARATION SUITABLE FOR ALLOWING ITS POSITION |
| DE29901613U1 (en) * | 1998-01-23 | 1999-04-08 | Aesculap Ag & Co Kg | Intervertebral implant |
| US6482233B1 (en) * | 1998-01-29 | 2002-11-19 | Synthes(U.S.A.) | Prosthetic interbody spacer |
| US6290724B1 (en) * | 1998-05-27 | 2001-09-18 | Nuvasive, Inc. | Methods for separating and stabilizing adjacent vertebrae |
| US6368325B1 (en) * | 1998-05-27 | 2002-04-09 | Nuvasive, Inc. | Bone blocks and methods for inserting bone blocks into intervertebral spaces |
| WO2000007527A1 (en) * | 1998-08-03 | 2000-02-17 | Synthes Ag Chur | Intervertebral allograft spacer |
| WO2000010474A1 (en) * | 1998-08-21 | 2000-03-02 | Synthes Ag Chur | Bone-anchoring element with snap-in spherical head |
| US6090143A (en) * | 1998-09-21 | 2000-07-18 | Meriwether; Michael W. | Box cage for intervertebral body fusion |
| EP1117995A1 (en) * | 1998-10-09 | 2001-07-25 | Simon Feldberg | Method and apparatus for determining and evaluating bacterial populations |
| CA2347472C (en) * | 1998-10-15 | 2008-02-12 | Synthes (U.S.A.) | Telescopic vertebral prosthesis |
| EP1123054A4 (en) * | 1998-10-21 | 2006-06-21 | Roger P Jackson | Spinal fusion apparatus and method |
| US6371986B1 (en) * | 1998-10-27 | 2002-04-16 | George W. Bagby | Spinal fusion device, bone joining implant, and vertebral fusion implant |
| ATE293411T1 (en) * | 1998-10-30 | 2005-05-15 | Michelson Gary K | SELF-REAVING, ROTATABLE, INSERTABLE SPONDYLOSUS IMPLANT |
| US6648895B2 (en) * | 2000-02-04 | 2003-11-18 | Sdgi Holdings, Inc. | Methods and instrumentation for vertebral interbody fusion |
| US6743234B2 (en) * | 1999-02-04 | 2004-06-01 | Sdgi Holdings, Inc. | Methods and instrumentation for vertebral interbody fusion |
| DE19912914C1 (en) * | 1999-03-22 | 2000-09-14 | Schott Glas | Process for the production of decors on substrates made of glass, glass ceramic or ceramic |
| AU4246000A (en) * | 1999-04-16 | 2000-11-02 | Nuvasive, Inc. | Articulation systems for positioning minimally invasive surgical tools |
| US6485518B1 (en) * | 1999-12-10 | 2002-11-26 | Nuvasive | Facet screw and bone allograft intervertebral support and fusion system |
| TW431172U (en) * | 2000-02-02 | 2001-04-21 | Lin Jr Yi | Device with side plate for fastening and restoring spine |
| AU774707B2 (en) * | 2000-02-22 | 2004-07-08 | Warsaw Orthopedic, Inc. | Anterior impacted bone graft and driver instruments |
| CA2395390A1 (en) * | 2000-02-22 | 2001-08-30 | Sdgi Holdings, Inc. | Instruments and techniques for disc space preparation |
| AU2001252973A1 (en) * | 2000-04-17 | 2001-10-30 | Purdue Research Foundation | Biosensor and related method |
| WO2002004169A2 (en) * | 2000-07-10 | 2002-01-17 | C.M.E. Blasting & Mining Equipment Ltd. | Grinding apparatus with articulated arm |
| US6500206B1 (en) * | 2000-09-15 | 2002-12-31 | Donald W. Bryan | Instruments for inserting spinal vertebral implant |
| US6443987B1 (en) * | 2000-09-15 | 2002-09-03 | Donald W. Bryan | Spinal vertebral implant |
| US6692434B2 (en) * | 2000-09-29 | 2004-02-17 | Stephen Ritland | Method and device for retractor for microsurgical intermuscular lumbar arthrodesis |
| US20030149368A1 (en) | 2000-10-24 | 2003-08-07 | Hennemann Willard W. | Method and apparatus for locating and detecting vascular plaque via impedence and conductivity measurements, and for cryogenically passivating vascular plaque and inhibiting vascular plaque progression and rupture |
| DE60201945T2 (en) * | 2001-02-04 | 2005-12-01 | Michelson, Gary Karlin, Los Angeles | Instrument for introducing and spreading an intervertebral fusion implant |
| US6607559B2 (en) * | 2001-07-16 | 2003-08-19 | Spine Care, Inc. | Trial intervertebral distraction spacers |
| US6863689B2 (en) * | 2001-07-16 | 2005-03-08 | Spinecore, Inc. | Intervertebral spacer having a flexible wire mesh vertebral body contact element |
| US20020138147A1 (en) * | 2001-03-22 | 2002-09-26 | Surgical Dynamics, Inc. | Apparatus for fusing adjacent bone structures |
| US6719794B2 (en) * | 2001-05-03 | 2004-04-13 | Synthes (U.S.A.) | Intervertebral implant for transforaminal posterior lumbar interbody fusion procedure |
| US6524320B2 (en) * | 2001-05-15 | 2003-02-25 | Endius Incorporated | Cannula for receiving surgical instruments |
| US7695478B2 (en) * | 2001-07-16 | 2010-04-13 | Spinecore, Inc. | Insertion tool for use with intervertebral spacers |
| US7153310B2 (en) * | 2001-07-16 | 2006-12-26 | Spinecore, Inc. | Vertebral bone distraction instruments |
| US6436102B1 (en) * | 2001-07-16 | 2002-08-20 | Third Millennium Engineering, Llc | Method of distracting vertebral bones |
| US6471725B1 (en) * | 2001-07-16 | 2002-10-29 | Third Millenium Engineering, Llc | Porous intervertebral distraction spacers |
| US6805716B2 (en) * | 2001-07-16 | 2004-10-19 | Spine Core, Inc. | Orthopedic device set for reorienting vertebral bones for the treatment of scoliosis |
| US6890356B2 (en) * | 2001-07-16 | 2005-05-10 | Spinecore, Inc. | Surgical method of treating scoliosis |
| US6554864B2 (en) * | 2001-07-16 | 2003-04-29 | Spinecore, Inc | Surgical method of treating scoliosis |
| US6428544B1 (en) * | 2001-07-16 | 2002-08-06 | Third Millennium Engineering, Llc | Insertion tool for use with trial intervertebral distraction spacers |
| US7722675B2 (en) * | 2001-07-16 | 2010-05-25 | Spinecore, Inc. | Instruments for reorienting vertebral bones for the treatment of scoliosis |
| US6562047B2 (en) * | 2001-07-16 | 2003-05-13 | Spine Core, Inc. | Vertebral bone distraction instruments |
| US8038717B2 (en) * | 2001-07-16 | 2011-10-18 | Spinecore, Inc. | Method of distracting vertebral bones |
| US6478801B1 (en) * | 2001-07-16 | 2002-11-12 | Third Millennium Engineering, Llc | Insertion tool for use with tapered trial intervertebral distraction spacers |
| US6447548B1 (en) * | 2001-07-16 | 2002-09-10 | Third Millennium Engineering, Llc | Method of surgically treating scoliosis |
| US20030014115A1 (en) * | 2001-07-16 | 2003-01-16 | Ralph James D. | Insertion tool for use with intervertebral spacers |
| US7077864B2 (en) * | 2002-02-12 | 2006-07-18 | Cross Medical Products, Inc. | Vertebral interbody cage with translatable locking screw |
| US7236821B2 (en) | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
| EP1344493B1 (en) * | 2002-03-12 | 2009-09-02 | Cervitech, Inc. | Instument set for insertion of intervertebral prostheses |
| US6945933B2 (en) * | 2002-06-26 | 2005-09-20 | Sdgi Holdings, Inc. | Instruments and methods for minimally invasive tissue retraction and surgery |
| US7083625B2 (en) * | 2002-06-28 | 2006-08-01 | Sdgi Holdings, Inc. | Instruments and techniques for spinal disc space preparation |
| CN100487133C (en) | 2002-07-20 | 2009-05-13 | 艾森生物(杭州)有限公司 | Testing apparatuses and methods based impedance |
| DE10248170A1 (en) * | 2002-10-16 | 2004-04-29 | Advanced Medical Technologies Ag | Implant for insertion between vertebras of a spinal column comprises two sides whose outer surfaces at the start of a vertebra spreading process converge towards the free ends of the sides |
| US7063725B2 (en) * | 2002-10-21 | 2006-06-20 | Sdgi Holdings, Inc. | Systems and techniques for restoring and maintaining intervertebral anatomy |
| US7125425B2 (en) * | 2002-10-21 | 2006-10-24 | Sdgi Holdings, Inc. | Systems and techniques for restoring and maintaining intervertebral anatomy |
| US7364589B2 (en) * | 2003-02-12 | 2008-04-29 | Warsaw Orthopedic, Inc. | Mobile bearing articulating disc |
| US7326216B2 (en) * | 2003-04-02 | 2008-02-05 | Warsaw Orthopedic, Inc. | Methods and instrumentation for positioning implants in spinal disc space in an anterior lateral approach |
| US7645232B2 (en) * | 2003-05-16 | 2010-01-12 | Zimmer Spine, Inc. | Access device for minimally invasive surgery |
| US20050021040A1 (en) * | 2003-07-21 | 2005-01-27 | Rudolf Bertagnoli | Vertebral retainer-distracter and method of using same |
| US7905840B2 (en) * | 2003-10-17 | 2011-03-15 | Nuvasive, Inc. | Surgical access system and related methods |
| CA2550274A1 (en) * | 2003-11-12 | 2005-05-26 | Acea Biosciences, Inc. | Real time electronic cell sensing systems and applications for cell-based assays |
| DE20320974U1 (en) * | 2003-12-11 | 2005-08-25 | Deltacor Gmbh | Surgical backbone implant is positioned between adjacent vertebrae and consists of two concentric cylinders with interlocking fingers in cruciform array, where the cylinder inner faces bear a thread |
| CN101511292B (en) | 2005-03-28 | 2011-04-06 | 明诺医学有限公司 | Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues |
| US7749269B2 (en) * | 2005-03-28 | 2010-07-06 | Warsaw Orthopedic, Inc. | Spinal system and method including lateral approach |
| FR2888744B1 (en) * | 2005-07-21 | 2007-08-24 | Charles Khalife | ROTARY INTERINEABLE DEVICE |
| EP2079359A1 (en) | 2006-09-29 | 2009-07-22 | Philometron, Inc. | Foreign body response detection in an implanted device |
| WO2014078815A1 (en) * | 2012-11-16 | 2014-05-22 | Indicator Systems International, Inc. | Electrochemical determination of infection |
-
2009
- 2009-05-07 DK DK09742353.7T patent/DK2271933T3/en active
- 2009-05-07 ES ES09742353T patent/ES2401235T3/en active Active
- 2009-05-07 CN CN200980116087.6A patent/CN102016575B/en active Active
- 2009-05-07 CA CA2723130A patent/CA2723130A1/en not_active Abandoned
- 2009-05-07 JP JP2011507982A patent/JP2011520118A/en active Pending
- 2009-05-07 WO PCT/GB2009/001132 patent/WO2009136157A2/en active Application Filing
- 2009-05-07 EP EP09742353A patent/EP2271933B1/en active Active
- 2009-05-07 US US12/990,921 patent/US10094818B2/en active Active
- 2009-05-07 PL PL09742353T patent/PL2271933T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2401235T3 (en) | 2013-04-18 |
| DK2271933T3 (en) | 2013-04-02 |
| PL2271933T3 (en) | 2013-05-31 |
| US10094818B2 (en) | 2018-10-09 |
| EP2271933A2 (en) | 2011-01-12 |
| WO2009136157A2 (en) | 2009-11-12 |
| WO2009136157A3 (en) | 2010-01-28 |
| CN102016575B (en) | 2014-12-03 |
| CN102016575A (en) | 2011-04-13 |
| US20110144469A1 (en) | 2011-06-16 |
| EP2271933B1 (en) | 2012-12-19 |
| JP2011520118A (en) | 2011-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2271933B1 (en) | A system and method for cell characterisation | |
| JP2011520118A5 (en) | ||
| Ludwig et al. | Chronic neural recordings using silicon microelectrode arrays electrochemically deposited with a poly (3, 4-ethylenedioxythiophene)(PEDOT) film | |
| Rahman et al. | Effect of electrode geometry on the impedance evaluation of tissue and cell culture | |
| CN103126672B (en) | Vesica urinaria urine accumulation real-time monitoring method and device based on bioelectrical impedance | |
| Alcaide et al. | Boron-doped nanocrystalline diamond electrodes for neural interfaces: in vivo biocompatibility evaluation | |
| US20020165464A1 (en) | Assessment of organs for transplant, xenotransplant, and predicting time of death | |
| Rahman et al. | Cell culture monitoring by impedance mapping using a multielectrode scanning impedance spectroscopy system (CellMap) | |
| Siddiquei et al. | Electrical cell-substrate impedance sensing (ECIS) based biosensor for characterization of DF-1 cells | |
| EP3246697B1 (en) | Method and system for producing a sheetlike cell culture | |
| García-Alonso et al. | In situ cell culture monitoring on a Ti–6Al–4V surface by electrochemical techniques | |
| JP2012037435A (en) | Method and device for detecting cell behavior | |
| Schröter et al. | Infection monitoring in wounds | |
| Shedden et al. | Towards a self-reporting coronary artery stent—Measuring neointimal growth associated with in-stent restenosis using electrical impedance techniques | |
| EP3210014B1 (en) | A device comprising a multi electrode array (mea) | |
| Caviglia et al. | Quantitative label-free cell proliferation tracking with a versatile electrochemical impedance detection platform | |
| CN107354087A (en) | A kind of Myocyte growth condition monitoring system based on degradable biological sensor | |
| KR20140047977A (en) | Real-time monitoring or diagnostic method for the stem cell senescence by measuring the electric cell-substrate impedance | |
| Das et al. | Electrical characterization of suspended HeLa cells using ECIS based biosensor | |
| EP3189775A1 (en) | Biosensor for monitoring bone healing | |
| Ferrario et al. | Electrochemical impedance spectroscopy study of the cells adhesion over microelectrodes array | |
| RU2796686C1 (en) | Device and method for measuring biopotentials in germinating seeds to determine optimal modes of their processing with a pulsed electric field | |
| CN113740423B (en) | EQCM method for detecting cell morphology change and cell adhesion characteristic change in real time | |
| Pérez-García et al. | Towards bio-impedance based labs: A review | |
| Hannah et al. | Rapidly detected common wound pathogens via easy-to-use electrochemical sensors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20150507 |